Agilent Technologies Inc. reported orders of $995 million, up 2 percent over one year ago, for the first fiscal quarter ended Jan. 31, 2015, and revenues of $1.03 billion, also up 2 percent compared with one year ago. Orders and revenues each grew 6 percent on a currency adjusted basis (3).
First-quarter GAAP income from continuing operations was $102 million, or $0.30 per share. Last year's first-quarter GAAP income from continuing operations was $121 million, or $0.36 per share.
During the first quarter, Agilent had intangible amortization of $43 million, transformation costs of $12 million and a tax benefit of $24 million. Excluding these items and $6 million of other net costs, Agilent reported first-quarter adjusted income from continuing operations of $139 million, or $0.41 per share(1).
"Agilent delivered a solid start to the year," said Bill Sullivan, Agilent CEO. "The strength of our core analytical business drove our success, offsetting currency headwinds and challenges within our diagnostics and genomics business."
"Looking ahead, we are confident in the strength of our new product portfolio to sustain growth as well as our ability to address some current business challenges and accelerate achievement of our long-term operating model," said Mike McMullen, Agilent president, COO and CEO-elect.
To view an unabridged version of this press release, visit: http://www.agilent.com/about/newsroom/presrel/2015/17feb-gp15002.html
